137 related articles for article (PubMed ID: 34927243)
1. MyD88 in myofibroblasts regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation.
Yuan Q; Zhang J; Liu Y; Chen H; Liu H; Wang J; Niu M; Hou L; Wu Z; Chen Z; Zhang J
J Pathol; 2022 Apr; 256(4):414-426. PubMed ID: 34927243
[TBL] [Abstract][Full Text] [Related]
2. MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization.
Liu Y; Chen H; Yan X; Zhang J; Deng Z; Huang M; Gu J; Zhang J
Cell Commun Signal; 2024 Jan; 22(1):86. PubMed ID: 38291436
[TBL] [Abstract][Full Text] [Related]
3. CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis via ERK-Dependent PKM2 Nuclear Relocalization and Activation.
Wong TL; Ng KY; Tan KV; Chan LH; Zhou L; Che N; Hoo RLC; Lee TK; Richard S; Lo CM; Man K; Khong PL; Ma S
Hepatology; 2020 Apr; 71(4):1279-1296. PubMed ID: 31469916
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment.
Liu WT; Jing YY; Gao L; Li R; Yang X; Pan XR; Yang Y; Meng Y; Hou XJ; Zhao QD; Han ZP; Wei LX
Cell Death Differ; 2020 Jan; 27(1):85-101. PubMed ID: 31065105
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts.
Satyanarayana G; Turaga RC; Sharma M; Wang S; Mishra F; Peng G; Deng X; Yang J; Liu ZR
Theranostics; 2021; 11(19):9331-9341. PubMed ID: 34646373
[No Abstract] [Full Text] [Related]
6. P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.
Dou C; Liu Z; Tu K; Zhang H; Chen C; Yaqoob U; Wang Y; Wen J; van Deursen J; Sicard D; Tschumperlin D; Zou H; Huang WC; Urrutia R; Shah VH; Kang N
Gastroenterology; 2018 Jun; 154(8):2209-2221.e14. PubMed ID: 29454793
[TBL] [Abstract][Full Text] [Related]
7. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.
Baglieri J; Brenner DA; Kisseleva T
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959975
[TBL] [Abstract][Full Text] [Related]
8. MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization.
Zhang J; Liu Y; Chen H; Yuan Q; Wang J; Niu M; Hou L; Gu J; Zhang J
Cell Death Dis; 2022 Apr; 13(4):411. PubMed ID: 35484116
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog controls hepatic stellate cell fate by regulating metabolism.
Chen Y; Choi SS; Michelotti GA; Chan IS; Swiderska-Syn M; Karaca GF; Xie G; Moylan CA; Garibaldi F; Premont R; Suliman HB; Piantadosi CA; Diehl AM
Gastroenterology; 2012 Nov; 143(5):1319-1329.e11. PubMed ID: 22885334
[TBL] [Abstract][Full Text] [Related]
11. MyD88 in myofibroblasts enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization.
Yuan Q; Gu J; Zhang J; Liu S; Wang Q; Tian T; Chen Z; Zhang J
Cell Rep; 2021 Feb; 34(5):108724. PubMed ID: 33535045
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis.
Zheng D; Jiang Y; Qu C; Yuan H; Hu K; He L; Chen P; Li J; Tu M; Lin L; Chen H; Lin Z; Lin W; Fan J; Cheng G; Hong J
Am J Pathol; 2020 Nov; 190(11):2267-2281. PubMed ID: 32805235
[TBL] [Abstract][Full Text] [Related]
13. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.
Zhou Q; Yin Y; Yu M; Gao D; Sun J; Yang Z; Weng J; Chen W; Atyah M; Shen Y; Ye Q; Li CW; Hung MC; Dong Q; Zhou C; Ren N
Redox Biol; 2022 Oct; 56():102458. PubMed ID: 36116159
[TBL] [Abstract][Full Text] [Related]
14. Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression.
Liu Z; Mo H; Liu R; Niu Y; Chen T; Xu Q; Tu K; Yang N
Cell Death Dis; 2021 Dec; 12(12):1134. PubMed ID: 34873170
[TBL] [Abstract][Full Text] [Related]
15. S100A4 promotes hepatocellular carcinogenesis by intensifying fibrosis-associated cancer cell stemness.
Li Y; Wang J; Song K; Liu S; Zhang H; Wang F; Ni C; Zhai W; Liang J; Qin Z; Zhang J
Oncoimmunology; 2020; 9(1):1725355. PubMed ID: 32117590
[TBL] [Abstract][Full Text] [Related]
16. MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis.
Mohs A; Kuttkat N; Otto T; Youssef SA; De Bruin A; Trautwein C
Carcinogenesis; 2020 Apr; 41(2):171-181. PubMed ID: 30770929
[TBL] [Abstract][Full Text] [Related]
17. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis.
Filliol A; Saito Y; Nair A; Dapito DH; Yu LX; Ravichandra A; Bhattacharjee S; Affo S; Fujiwara N; Su H; Sun Q; Savage TM; Wilson-Kanamori JR; Caviglia JM; Chin L; Chen D; Wang X; Caruso S; Kang JK; Amin AD; Wallace S; Dobie R; Yin D; Rodriguez-Fiallos OM; Yin C; Mehal A; Izar B; Friedman RA; Wells RG; Pajvani UB; Hoshida Y; Remotti HE; Arpaia N; Zucman-Rossi J; Karin M; Henderson NC; Tabas I; Schwabe RF
Nature; 2022 Oct; 610(7931):356-365. PubMed ID: 36198802
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological significance of myeloid differentiation factor 88 expression in human hepatocellular carcinoma tissues.
Kinowaki K; Soejima Y; Kumagai A; Kondo F; Sano K; Fujii T; Kitagawa M; Fukusato T
Pathol Int; 2017 May; 67(5):256-263. PubMed ID: 28370778
[TBL] [Abstract][Full Text] [Related]
19. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
20. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]